Scientists have published an analysis of Parkinson’s disease research papers with the highest Altmetric Attention Scores. The publication is the first in a series aimed at utilizing Altmetric data to provide a more nuanced understanding of how the announcements of new medical discoveries affect the wide-range of disease-specific stakeholders including researchers, funders, care providers, and patients.